Reuters: FDA panel: Two asthma drugs risky but Advair OK

[NaDiNe]

FDA panel: Two asthma drugs risky but Advair OK
      

ROCKVILLE, Maryland (Reuters) - GlaxoSmithKline Plc's widely prescribed drug Advair is safe enough for treating asthma but two lesser-used medicines are too risky, a U.S. advisory panel ruled on Thursday.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login